Maze Therapeutics director granted 18,000 stock options
Maze Therapeutics, Inc. director Richard H. Scheller received a grant of stock options covering 18,000 shares of common stock.
Rhea-AI Filing Summary
Maze Therapeutics, Inc. director Richard H. Scheller received a grant of stock options covering 18,000 shares of common stock. The options have an exercise price of $23.58 per share and expire on June 7, 2036.
The option award vests and becomes fully exercisable on the earlier of the company’s 2027 annual stockholders meeting or June 8, 2027, as long as Scheller continues to serve the company through that vesting date. This is a compensation-related grant rather than an open‑market transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 18,000 shares
Grant/Award
1 txn
Insider
SCHELLER RICHARD H
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 18,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 18,000 contracts (Direct)
Footnotes (1)
- F1. The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.
Key Figures
Option grant size: 18,000 options
Exercise price: $23.58 per share
Underlying shares: 18,000 shares
+3 more
6 metrics
Option grant size
18,000 options
Stock Option (Right to Buy) granted to director
Exercise price
$23.58 per share
Conversion or exercise price of stock option
Underlying shares
18,000 shares
Common Stock underlying granted options
Options after grant
18,000 options
Total derivative securities following transaction
Option expiration date
June 7, 2036
Expiration date of granted stock options
Vesting date outside meeting
June 8, 2027
Alternative vesting date if earlier meeting not held
Key Terms
Stock Option (Right to Buy), Common Stock, exercise price, expiration date, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 23.5800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-07T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual stockholders meeting financial
"the issuer's 2027 annual stockholders meeting"
vest financial
"The option shall vest and be fully exercisable"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Maze Therapeutics (MAZE) report for Richard H. Scheller?
Maze Therapeutics reported that director Richard H. Scheller received a grant of stock options for 18,000 shares of common stock. This is a compensation-related award, not an open-market trade, and represents a right to buy shares at a fixed exercise price.
How many Maze Therapeutics (MAZE) options were granted to Richard H. Scheller and at what price?
Richard H. Scheller was granted stock options covering 18,000 shares of Maze Therapeutics common stock. The options carry an exercise price of $23.58 per share, setting the price at which he can later purchase the underlying shares if he chooses to exercise.
When do Richard H. Scheller’s Maze Therapeutics (MAZE) stock options vest?
The stock options granted to Richard H. Scheller will vest and become fully exercisable on the earlier of Maze Therapeutics’ 2027 annual stockholders meeting or June 8, 2027. Vesting is conditioned on his continued service with the company through that vesting date.
When do the newly granted Maze Therapeutics (MAZE) options to Richard H. Scheller expire?
The granted stock options to Richard H. Scheller expire on June 7, 2036. After that expiration date, any unexercised portion of the options can no longer be used to purchase Maze Therapeutics common shares under this award.
Is Richard H. Scheller’s Maze Therapeutics (MAZE) option grant an open-market purchase or sale?
The transaction is a grant of stock options as compensation, not an open-market purchase or sale. It provides Scheller with the right to buy Maze Therapeutics shares at $23.58 in the future, subject to vesting and before expiration.
AI-generated analysis. How Rhea-AI works. Not financial advice.
